siRNA, Anti-HLA-DRB5, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT11045WQ-2OMe)

The product SIRGT11045WQ-2OMe is a type of small interfering RNA (siRNA) that targets HLA-DRB5 gene and regulates the expression of gene. The siRNA interferes with the expression of HLA-DRB5 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_002125.3
Related Diseases Pityriasis Rosea, Trochlear Nerve Disease
Purification HPLC
Target Gene
Gene ID 3127
Uniprot ID Q30154
Sub Cat Target Species Modification Scale  
SIRGT12045WQ-2F HLA-DRB5 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT13045WQ-2MOE HLA-DRB5 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT14045WQ-LNA HLA-DRB5 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT11045WQ-RB HLA-DRB5 Human Ribo-modified Inquiry
SIRGT12045WQ-BB HLA-DRB5 Human Backbone-modified Inquiry

Related Products